Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy
Thomas A. Waldmann, Jing Chen
Annual Review of Immunology (2017) Vol. 35, Iss. 1, pp. 533-550
Open Access | Times Cited: 150

Showing 26-50 of 150 citing articles:

<p>Cannabidiol as a Novel Therapeutic for Immune Modulation</p>
Nadia Peyravian, Sapna K. Deo, Sylvia Daunert, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 131-140
Open Access | Times Cited: 53
JAK1: Number one in the family; number one in inflammation?
Francesca Romana Spinelli, Robert A. Colbert, Massimo Gadina
Lara D. Veeken (2021) Vol. 60, Iss. Supplement_2, pp. ii3-ii10
Open Access | Times Cited: 42
Genetic and epigenetic insights into cutaneous T-cell lymphoma
Cornelis P. Tensen, Koen D. Quint, Maarten H. Vermeer
Blood (2021) Vol. 139, Iss. 1, pp. 15-33
Open Access | Times Cited: 42
Chitosan-coated artesunate protects against ulcerative colitis via STAT6-mediated macrophage M2 polarization and intestinal barrier protection
Ya Tao, Lei Xu, Xiaopan Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127680-127680
Closed Access | Times Cited: 19
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells
Toshiaki Yoshikawa, Yusuke Ito, Zhiwen Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101526-101526
Open Access | Times Cited: 6
Novel insights into the pathogenesis of T-cell lymphomas
John S. Van Arnam, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson
Blood (2018) Vol. 131, Iss. 21, pp. 2320-2330
Open Access | Times Cited: 54
Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?
Claire Speirs, Jamie J.L. Williams, Kirsten Riches‐Suman, et al.
Pharmacological Research (2017) Vol. 128, pp. 88-100
Open Access | Times Cited: 50
Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Naoki Oishi, Roberto N. Miranda, Andrew L. Feldman
PubMed (2019) Vol. 39, Iss. Suppl_1, pp. S14-S20
Closed Access | Times Cited: 50
Pathogenesis of Peripheral T Cell Lymphoma
Marco Pizzi, Elizabeth Margolskee, Giorgio Inghirami
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 293-320
Open Access | Times Cited: 47
Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
Yufei Wang, Anna Jia, Yujing Bi, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 1011-1011
Open Access | Times Cited: 46
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 37
Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract
Valérie Freiche, Nathalie Cordonnier, Mathieu Victor Paulin, et al.
Laboratory Investigation (2021) Vol. 101, Iss. 6, pp. 794-804
Open Access | Times Cited: 35
Deregulation of JAK2 signaling underlies primary cutaneous CD8<sup>+</sup> aggressive epidermotropic cytotoxic T-cell lymphoma
Armando N. Bastidas Torres, Davy Cats, Jacoba J. Out‐Luiting, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 702-714
Open Access | Times Cited: 33
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations
Alina Nicolae, Justine Bouilly, Diane Lara, et al.
Modern Pathology (2022) Vol. 35, Iss. 8, pp. 1126-1136
Open Access | Times Cited: 25
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
Shivani Thoidingjam, Sushmitha Sriramulu, Svend O. Freytag, et al.
Translational Medicine Communications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 13
A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia
Klara R. Klein, Sebastian Kollmann, Angela Hiesinger, et al.
Blood (2024) Vol. 143, Iss. 24, pp. 2474-2489
Open Access | Times Cited: 5
Management of Mycosis Fungoides and Sézary Syndrome With Oral Systemic Therapies
Jonathan D. Greenzaid, Sach Thakker, Ainsley J. Ruley, et al.
Journal of Cutaneous Medicine and Surgery (2025)
Closed Access
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
Danilo Fiore, Luca Vincenzo Cappelli, Zhaoqi Liu, et al.
Cell Reports Medicine (2025), pp. 102029-102029
Open Access
JAK3A573VandJAK3M511Imutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3/PD-L1 pathway
Ning Lou, Mengwei Yang, Zucheng Xie, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010783-e010783
Open Access
miR-200a-3p modulates gene expression in comorbid pain and depression: Molecular implication for central sensitization
Senthil Kumaran Satyanarayanan, Yin-Hwa Shih, Yeong‐Ray Wen, et al.
Brain Behavior and Immunity (2019) Vol. 82, pp. 230-238
Closed Access | Times Cited: 41
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
Anand K. Deva, Suzanne D. Turner, Marshall E. Kadin, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3861-3861
Open Access | Times Cited: 38
Development of new agents for peripheral T-cell lymphoma
Yuta Ito, Shinichi Makita, Kensei Tobinai
Expert Opinion on Biological Therapy (2019) Vol. 19, Iss. 3, pp. 197-209
Closed Access | Times Cited: 36
ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis
Qian Yuan, Gabriel Arellano, Igal Ifergan, et al.
Cell Reports (2021) Vol. 36, Iss. 8, pp. 109602-109602
Open Access | Times Cited: 32
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
Wenjing Zhang, Fuyan Shi, Yujia Kong, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 676-691
Open Access | Times Cited: 28

Scroll to top